small molecule

LYMPHOSEEK KIT

TECHNETIUM TC-99M TILMANOCEPT

Loss of exclusivityJanuary 2029latest FDA-listed patent expiry
CompanyCARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES

Drug detail

Brand nameLYMPHOSEEK KIT
Active ingredientTECHNETIUM TC-99M TILMANOCEPT
StrengthN/A
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMarch 2013
Marketing statusRX

Listed patents

PatentExpiresType
9439985January 2029product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.